Standout Papers

New insights into atypica... 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. New insights into atypical Alzheimer's disease in the era of biomarkers
    2021 388 citations Jonathan Graff‐Radford, Keir Yong et al. The Lancet Neurology profile →

Immediate Impact

62 hit
Sub-graph 1 of 21

Citing Papers

Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma
2025 Hit
The therapeutic potential of circular RNAs
2025 Hit
2 intermediate papers

Works of Keir Yong being referenced

New insights into atypical Alzheimer's disease in the era of biomarkers
2021 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Keir Yong 467 372 331 172 163 65 1.1k
Kent M. Perryman 600 1.3× 503 1.4× 449 1.4× 199 1.2× 67 0.4× 35 1.4k
Jeremy A. Elman 546 1.2× 666 1.8× 301 0.9× 110 0.6× 241 1.5× 78 1.4k
J. Thomas Hutton 264 0.6× 235 0.6× 139 0.4× 91 0.5× 46 0.3× 48 1.3k
Zuzana Nedelská 715 1.5× 609 1.6× 444 1.3× 176 1.0× 194 1.2× 63 1.4k
Éloi Magnin 412 0.9× 298 0.8× 196 0.6× 156 0.9× 54 0.3× 89 1.0k
Jessica Alber 187 0.4× 246 0.7× 250 0.8× 146 0.8× 273 1.7× 32 1.0k
Pedro Gil 411 0.9× 414 1.1× 485 1.5× 253 1.5× 311 1.9× 59 1.5k
Mathieu Ceccaldi 458 1.0× 687 1.8× 277 0.8× 102 0.6× 123 0.8× 54 1.2k
Olivier Moreaud 364 0.8× 568 1.5× 300 0.9× 111 0.6× 83 0.5× 57 1.2k
Hilary W. Heuer 144 0.3× 620 1.7× 126 0.4× 139 0.8× 92 0.6× 35 957

All Works

Loading papers...

Rankless by CCL
2026